Published in Hepatitis Weekly, March 31st, 2003
According to a study from Japan, "the aim of this study was to identify hepatitis C virus (HCV) genotypes and to estimate their prevalence in various risk groups and the regional distribution in Uzbekistan."
"Preliminary serological screening of 1,269 subjects revealed 6.5% anti-HCV-positive in a general population, 27.1% in patient groups, and 51.7% among intravenous drug users," reported F. Kurbanov and coauthors, Nagoya City University, Graduate School of Medical Science.
"HCV genotypes of 104 anti-HCV-positive subjects were determined...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.